-+ 0.00%
-+ 0.00%
-+ 0.00%

PolyPid's D-PLEX100 Shows Lower Bacterial Burden in Surgical-Site Infections in Pooled Trial Analysis

PUBT·10/21/2026 12:03:02
Listen to the news
PolyPid's D-PLEX100 Shows Lower Bacterial Burden in Surgical-Site Infections in Pooled Trial Analysis
  • PolyPid will present exploratory pooled D-PLEX100 microbiology results from three randomized trials at IDWeek in Washington, D.C., on October 22, 2026.
  • D-PLEX100 with standard care showed lower bacterial burden in breakthrough surgical-site infections than standard care alone; infections also occurred later.
  • Multidrug-resistant organisms occurred in similar proportions across treatment groups, with no statistically significant difference in doxycycline resistance.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PolyPid Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610210800PRIMZONEFULLFEED9848835) on October 21, 2026, and is solely responsible for the information contained therein.